This observation, in the context of anti‐ACE2 IgM associating with severe disease in patients with SARS‐CoV‐2 (8), prompted us to investigate a Japanese anti‐MDA5‐positive DM cohort in which data were available from disease onset. Here, ACE2 is linked to dermatomyositis.